Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03164356 · ClinicalTrials.gov registry record · NA
Bioimpedance as a Diagnostic Tool for Assessing the Need for Socket Modification in Transtibial Amputees
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 68
- Enrollment target
NCT03164356 is a NA study that has completed, run by University of Washington. The registered enrollment target is 68 participants.
The verdict
NCT03164356, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
Study Summary
The purpose of the proposed study is to conduct research on individuals with lower limb amputation, evaluating if residual limb fluid volume data collected using a novel non-invasive device is beneficial towards prosthetic prescription, fit, and comfort as determined by amputee test subjects and practitioners (prosthetists). Participants' residual limb fluid volume will be monitored through bioimpedance analysis both before and after a practitioner-issued modification to the prosthesis as an observational cohort study and then as a blinded randomized control trial in which the data may or may not be shared with the practitioner before the modification is made to the prosthesis.
Interventions
- DEVICE Bioimpedance monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2016-11-09 |
| Est. Completion | 2020-12-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03164356
The ClinicalTrials.gov registry entry for NCT03164356 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bioimpedance monitor is the first listed.
NCT03164356 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03164356 about?
NCT03164356 is a clinical study titled "Bioimpedance as a Diagnostic Tool for Assessing the Need for Socket Modification in Transtibial Amputees". The purpose of the proposed study is to conduct research on individuals with lower limb amputation, evaluating if residual limb fluid volume data collected using a novel non-invasive device is beneficial towards prosthetic prescription, fit, and comfort as determined by amputee test subjects and pra...
What is the current status of trial NCT03164356?
This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2016-11-09. Estimated completion is 2020-12-23.
What interventions are being tested in trial NCT03164356?
The interventions under investigation include: Bioimpedance monitor (DEVICE).
Who is sponsoring clinical trial NCT03164356?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.